About
Technology
Issues
FAQ
Links
Official Page
Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.